Review Articles (peer reviewed)

  1. Eddleston MP and Mucke L (1993) Molecular profile of reactive astrocytes–Implications for their role in neurologic disease. Neuroscience 54: 15–36
  2. Mucke L and Eddleston M (1993) Astrocytes in infectious and immune-mediated diseases of the central nervous system. FASEB J. 7: 1226–1232
  3. Mattson MP, Barger SW, Furukawa K, Bruce AJ, Wyss-Coray T, Mark RJ, and Mucke L (1997) Cellular signaling roles of TGFb, TNFa and bAPP in brain injury responses and Alzheimer’s disease. Brain Res. Rev. 23: 47–61
  4. Wyss-Coray T and Mucke L (2002) Inflammation in neurodegenerative disease – A double-edged sword. Neuron 35: 419–432
  5. Palop JJ, Chin J, and Mucke L (2006) A network dysfunction perspective on neurodegenerative diseases. Nature 443: 768–773
  6. Roberson ED and Mucke L (2006) 100 years and counting: Prospects for defeating Alzheimer’s disease. Science 314: 781–784   
  7. Gan L and Mucke L (2008) Paths of convergence: Sirtuins in aging and neurodegeneration. Neuron 58: 10–14
  8. Palop JJ and Mucke L (2009) Epilepsy and cognitive impairments in Alzheimer’s disease. Arch. Neurol. 66: 435–440
  9. Palop JJ and Mucke L (2010) Synaptic depression and aberrant excitatory network activity in Alzheimer’s disease: two faces of the same coin? NeuroMolecular Med. 12: 48–55
  10. Sanchez-Mejia RO and Mucke L (2010) Phospholipase A2 and arachidonic acid in Alzheimer’s disease. Biochim. Biophys. Acta. 1801: 784–790
  11. Palop JJ and Mucke L (2010) Amyloid-β–induced neuronal dysfunction in Alzheimer’s disease: From synapses toward neural networks. Nat. Neurosci. 13: 812–818
  12. Morris M, Maeda S, Vossel K, and Mucke L (2011) The many faces of tau. Neuron 70: 410–426
  13. Huang Y and Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148: 1204–1222